Guanylyl cyclase C–induced immunotherapeutic responses opposing tumor metastases without autoimmunity
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
[引用][C] Guanylyl Cyclase C-Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity
AE SNOOK, BJ STAFFORD… - Journal of the …, 2008 - pascal-francis.inist.fr
Guanylyl Cyclase C-Induced Immunotherapeutic Responses Opposing Tumor Metastases
Without Autoimmunity CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Without Autoimmunity CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[PDF][PDF] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity
AE Snook, BJ Stafford, P Li, G Tan, L Huang… - J Natl Cancer …, 2008 - research.jefferson.edu
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
Guanylyl Cyclase C-Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity.
AE Snook, BJ Stafford, P Li, G Tan… - JNCI: Journal of the …, 2008 - search.ebscohost.com
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
[HTML][HTML] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity
AE Snook, BJ Stafford, P Li, G Tan… - JNCI Journal of the …, 2008 - ncbi.nlm.nih.gov
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
[PDF][PDF] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity
AE Snook, BJ Stafford, P Li, G Tan, L Huang, R Birbe… - J Natl Cancer Inst, 2008 - Citeseer
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity
AE Snook, BJ Stafford, P Li, G Tan… - Journal of the …, 2008 - pubmed.ncbi.nlm.nih.gov
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
[PDF][PDF] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity
AE Snook, BJ Stafford, P Li, G Tan, L Huang… - J Natl Cancer …, 2008 - academia.edu
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
[PDF][PDF] Guanylyl Cyclase C–Induced Immunotherapeutic Responses Opposing Tumor Metastases Without Autoimmunity
AE Snook, BJ Stafford, P Li, G Tan, L Huang… - J Natl Cancer …, 2008 - researchgate.net
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity.
AE Snook, BJ Stafford, P Li, G Tan, L Huang… - Journal of the …, 2008 - europepmc.org
Background One of the greatest impediments to cancer immunotherapy is the paucity of
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …
antigens that are tumor specific, sufficiently immunogenic, and shared among patients …